Leadership Overview
Zydus has 8 executives leading key functions including strategy, API operations, human resources, and corporate communications.
Driven by a commitment to global health, Zydus develops, manufactures, and distributes pharmaceutical products worldwide, impacting diverse markets through extensive research and development.
Driven by a commitment to global health, Zydus develops, manufactures, and distributes pharmaceutical products worldwide, impacting diverse markets through extensive research and development.
Leadership Roles at Zydus
Sanjeev Kumar - President
Sanjeev Kumar, the President at Zydus, directs strategic initiatives that advance the company's global pharmaceutical operations. Overseeing critical business segments, Kumar ensures alignment with Zydus's mission to deliver high-quality healthcare solutions across regulated and emerging markets. This leadership role involves driving operational excellence and fostering innovation within the organization. By focusing on market dynamics and product development pipelines, Sanjeev Kumar contributes significantly to Zydus's expansion and sustained growth in the competitive pharmaceutical landscape. The President's purview encompasses optimizing resource allocation and enhancing cross-functional collaboration to achieve key business objectives.
Mangesh Vaze - President, Api Business
Mangesh Vaze, the President, Api Business at Zydus, spearheads the strategic direction and operational execution of the Active Pharmaceutical Ingredients (API) division. Vaze's leadership ensures the robust development, manufacturing, and global distribution of APIs, which are foundational to Zydus's comprehensive product portfolio. This role demands meticulous oversight of quality control, regulatory compliance, and supply chain efficiency across Zydus's manufacturing sites in India, the United States, and Brazil. By driving innovation in API synthesis and production processes, Mangesh Vaze directly supports the company's ability to serve diverse markets, including North America, Europe, and Latin America, reinforcing Zydus's position as a key global supplier.
Kapil Maithal - President
Kapil Maithal, the President at Zydus, drives critical business functions that support the company's extensive pharmaceutical operations. Maithal's responsibilities encompass overseeing key strategic projects and operational enhancements designed to bolster Zydus's global market presence. This leadership position involves ensuring seamless integration of research, development, and manufacturing processes to meet the demands of regulated markets like the United States and Europe. By focusing on efficiency and strategic resource deployment, Kapil Maithal plays a vital part in Zydus's ongoing commitment to delivering accessible and high-quality pharmaceutical products worldwide, contributing to the company's overall growth trajectory.
Dr.Amrut Naik - President
Dr.Amrut Naik, the President at Zydus, directs significant aspects of the company's pharmaceutical development and manufacturing initiatives. Naik's leadership focuses on advancing Zydus's research capabilities and ensuring the efficient production of a wide array of pharmaceutical products. This role is crucial for maintaining Zydus's strong footprint in key global regions, including Latin America and South Africa, as well as serving emerging markets. By championing scientific innovation and operational rigor, Dr.Amrut Naik contributes directly to the company's mission of providing essential medicines and improving global health outcomes. The President's strategic oversight supports Zydus's competitive edge in the pharmaceutical industry.
Harish Sadana - President Corporate Matters
Harish Sadana, the President Corporate Matters at Zydus, manages essential corporate functions that underpin the company's global operations and strategic development. Sadana's purview includes overseeing critical administrative and strategic initiatives that ensure Zydus operates efficiently and compliantly across its international sites in India, the United States, and Brazil. This leadership role is vital for maintaining strong corporate governance and fostering an environment conducive to Zydus's expansive business activities. By focusing on the strategic alignment of corporate resources and stakeholder relations, Harish Sadana significantly contributes to Zydus's sustained success and its ability to navigate complex global markets effectively.
Rishikesh Raval - Group President, Human Resources & Corporate Communications
Rishikesh Raval, the Group President, Human Resources & Corporate Communications at Zydus, leads the strategic development and execution of human capital management and external relations. Raval's leadership ensures Zydus cultivates a skilled and motivated workforce across its global operations, supporting manufacturing sites and research facilities in India, the United States, and Brazil. This role is pivotal in shaping Zydus's corporate culture and enhancing its brand reputation in regulated and emerging markets worldwide. By driving initiatives in talent acquisition, employee development, and strategic communication, Rishikesh Raval significantly contributes to Zydus's organizational strength and its ability to achieve its overarching business objectives.
Kacharu Toshniwal - President
Kacharu Toshniwal, the President at Zydus, directs key operational strategies that enhance the company's pharmaceutical manufacturing and distribution capabilities. Toshniwal's leadership focuses on optimizing production processes and ensuring the consistent delivery of high-quality pharmaceutical products to global markets, including Europe and South Africa. This role is integral to Zydus's commitment to operational excellence and its ability to meet the diverse needs of customers worldwide. By driving efficiency and innovation within manufacturing operations, Kacharu Toshniwal significantly contributes to Zydus's market competitiveness and its mission to improve healthcare access through reliable pharmaceutical supply.
Nitin Parekh - President (Special Projects)
Nitin Parekh, the President (Special Projects) at Zydus, spearheads critical, high-impact initiatives that drive strategic growth and innovation across the organization. Parekh's leadership focuses on identifying and executing new opportunities that align with Zydus's long-term vision and market expansion goals in regions such as North America and Latin America. This role demands a forward-thinking approach to business development and the successful implementation of complex projects that enhance Zydus's competitive positioning. By driving specialized strategic endeavors, Nitin Parekh plays a crucial role in Zydus's ongoing evolution and its commitment to delivering advanced pharmaceutical solutions globally.
Explore Leadership Teams in Manufacturing
Akums, headquartered in Delhi, India, is an international WHO-GMP certified integrated pharmaceutical manufacturing company.
Company Leadership
YD
IG
Hetero is a global pharmaceutical company founded in 1993 and headquartered in India with operations across Asia, Europe, North America, South America, Africa, and the Middle East. The company specializes in manufacturing generic pharmaceuticals and is recognized as a major producer of anti-retroviral medications for HIV/AIDS treatment. Hetero develops and manufactures a wide range of pharmaceutical products while maintaining research facilities and production centers worldwide.
Company Leadership VS
KS

Founded in 1850 and headquartered in Johannesburg, South Africa, Aspen Pharmacare Holdings Limited is a global specialty and branded pharmaceutical company headquartered in Durban, South Africa. Operating across Africa, the Middle East, the Americas, Europe CIS, Australasia, and Asia, Aspen focuses on sterile injectables (including anaesthetics, anticoagulants, antithrombotics, analgesics, and hormone replacement therapies), over-the-counter medicines, and prescription products for conditions such as hypothyroidism, autoimmune disease, pain, gout, and inflammatory disorders. The company also manufactures active pharmaceutical ingredients and finished dose forms, including steriles, oral solids, liquids, semi-solids, biologicals, and heparins, supplying both its own brands and third-party customers worldwide.
Company Leadership
TS

RM
Pacira is the leading provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving patient outcomes. We have a drive and a desire to improve the world around us and make a meaningful difference in the lives of patients, families, communities, and society. (Nasdaq: PCRX) is a provider of non-opioid pain management and regenerative health solutions manufacturing.
Company Leadership


